The ethics quagmire and random clinical trials.
D001205:Ascorbic Acid / Q000627:therapeutic use; D026688:Bioethical Issues; D002648:Child; D002662:Child Health Services; D002986:Clinical Trials as Topic; D003139:Common Cold / Q000188:drug therapy; D035881:Compensation and Redress; D035061:Control Groups; D003325:Coronary Care Units; D003327:Coronary Disease / Q000628:therapy; D030881:Disclosure; D004812:Epidemiologic Methods; D028741:Ethics Committees, Clinical; D028744:Ethics Committees, Research; D004992:Ethics, Medical; D035082:Federal Government; D005260:Female; D005921:Glomerulonephritis / Q000517:prevention & control; D033161:Government Regulation; D006805:Human Experimentation; D006801:Humans; D007258:Informed Consent; D007351:Insurance, Liability; D007603:Jurisprudence; D008297:Male; D008427:Maternal Health Services; D028681:Moral Obligations; D033281:Nontherapeutic Human Experimentation; D010401:Penicillin G Benzathine / Q000627:therapeutic use; D010919:Placebos; D011367:Professional Staff Committees; D012141:Respiratory Tract Infections / Q000188:drug therapy; D012213:Rheumatic Fever / Q000517:prevention & control; D018570:Risk Assessment; D013290:Streptococcal Infections / Q000188:drug therapy; D036302:Therapeutic Human Experimentation; D014481:United States; D028761:Withholding Treatment
D010919:Placebos; D001205:Ascorbic Acid; D010401:Penicillin G Benzathine